Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis

Stopped Protracted gastrointestinal symptoms were experienced by most patients who were subsequently found to be in the treatment arm on LPV/r. This observation resulted in cessation of enrolment and a decision not to continue the RCT

Conditions

• Primary Biliary Cirrhosis

Interventions

• DRUG: TDF/FTC/LPV/r
• DRUG: Placebo

Sponsor

University of Alberta

Collaborators

• [object Object]
• [object Object]
• [object Object]